PTC Therapeutics -- PTCT Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTC Therapeutics -- PTCT

PTCT 68.10

+1.0%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	4/16/2015 6:38:52 PM
	Read Replies (1) of 38

How he found them, I'll never know. Been looking for an hour. But Andy Biotech has a list of the late breaking abstracts for American Acad. Neurology annual meeting, and RG7800 (SMA program) makes the list.... "SMN2 splicing modifier RG7800 shows dose-dependent increase of full length SMN2 mRNA in first-in-human study" Heidemarie Kletzl, PharmD, PhD, Basel, Switzerland"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next